13 резултата
Alopecia (baldness or deficient hair growth) is a condition which leads to more or less disabling or discomfort to the individual suffering therefrom, ranging from minor cosmetic disadvantages to severe psychological consequences.
Alopecia has a number of etiologies.
The most common form of alopecia
Alopecia (baldness or deficient hair growth) is a condition which leads to more or less disabling or discomfort to the individual suffering therefrom, ranging from minor cosmetic disadvantages to severe psychological consequences.
Alopecia has a number of etiologies.
The most common form of alopecia
TECHNICAL FIELD
This invention relates to novel potassium channel blocking agents, and their use in the preparation of pharmaceutical compositions.
Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the
This application is the national phase of PCT application PCT/EP2006/060643 filed on Mar. 13, 2006 and claims priority under 35 U.S.C. 119(e) on Provisional Application No(s). 60/661,149 filed on Mar. 14, 2005 and under 35 U.S.C. 119(a) on patent application No(s). PA 2005 00366 filed in Denamark on
TECHNICAL FIELD
This invention relates to novel potassium channel blocking agents, and their use in the preparation of pharmaceutical compositions.
Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the
TECHNICAL FIELD
This invention relates to novel potassium channel blocking agents, and their use in the preparation of pharmaceutical compositions.
Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the
TECHNICAL FIELD
This invention relates to novel indazolyl derivatives useful as potassium channel modulating agents, and their use in the preparation of pharmaceutical compositions.
Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases
FIELD OF THE INVENTION
The present invention describes novel nitrosated and/or nitrosylated potassium channel activators, and novel compositions comprising at least one nitrosated and/or nitrosylated potassium channel activator, and, optionally, at least one compound that donates, transfers or
FIELD OF THE INVENTION
The present invention describes novel nitrosated and/or nitrosylated potassium channel activators, and novel compositions comprising at least one nitrosated and/or nitrosylated potassium channel activator, and, optionally, at least one compound that donates, transfers or
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
TECHNICAL FIELD OF INVENTION
This invention relates to the field of treatment of hair loss.
BACKGROUND OF THE INVENTION
Hair loss is a common condition in humans. While not a physically injurious condition, hair loss can
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
TECHNICAL FIELD OF INVENTION
This invention relates to the field of treatment of hair loss.
BACKGROUND OF THE INVENTION
Hair loss is a common condition in humans. While not a physically injurious condition, hair loss can
This application claims the benefit of U.S. Provisional Application No. 60/006,001, filed Oct. 26, 1995.
FIELD OF THE INVENTION
The present invention provides novel compounds, novel compositions, methods of their use and methods of their manufacture, where such compounds are generally
CROSS-REFERENCE TO RELATED APPLICATIONS
This is a non-provisional application based on Provisional application, Ser. No. 60/005,832, filed Oct. 23, 1995 (now abandoned).
FIELD OF THE INVENTION
The present invention provides novel compounds, novel compositions, methods of their use and methods of